Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06248554 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06248554 · ClinicalTrials.gov record · last posted 2026-08-10

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

Name: Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation — clinical trial record (NCT06248554)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhaseNot applicable

SponsorChen Xiaoping

Started2021-01-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

For early-stage hepatocellular carcinoma, i.e. Barcelona Clinical Liver Cancer Stage 0, ablation is the standard treatment with a comparable prognosis and less risk of ablation compared with liver resection. However, ablation is demanding on the surgeon and patients often face early recurrence if ablation is not complete. Therefore, it is necessary to find reasonable adjuvant treatment to consolidate the effect of microwave therapy.

Protocol amendment history 3 changes detected by DataLookout

2026-08-11

Trial completed

2026-08-11

Enrollment increased: 200 → 251 participants

2026-08-11

Completion pushed: 2025-12-31 → 2026-07-30

Trial Details

NCT Number	NCT06248554
Lead Sponsor	Chen Xiaoping
Conditions	Hepatocellular Carcinoma
Enrollment	251 participants
Start Date	2021-01-01
Primary Completion	2024-12-31 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-10